Shares of CVS Health Corp. CVS inched 0.44% higher to $54.27 Wednesday, on what proved to be an all-around favorable trading ...

CVS has acquired the pharmacy side of the business, which means that the popular soda fountains will be closing too.

J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

A row of shelves in a retail pharmacy, demonstrating the variety of drugs and over-the-counter products. Cramer stated that ...

CVS pharmacists, clerks and technicians voted Friday to ratify a new three-year contract with the pharmacy. The 7,000-plus ...

The FDA announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter ...

An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The ...

But today, according to the Federal Trade Commission, the six largest PBMs — CVS Caremark, Express Scripts ... leaving patients to pay more at the pharmacy counter. The abusive practices of PBMs take ...

GoodRx and pharmacy benefit managers CVS Caremark, Express Scripts, MedImpact and Navitus Health Solutions are facing class-action lawsuits accusing them of colluding to super press reimbursements to ...

CVS Health (NYSE:CVS) offers a wide range of health solutions in the U.S., including health insurance products and services, ...

Before we dive into the specifics of this recent uptick, it’s worth looking at how CVS Health has been performing on a year-to-date (YTD) basis compared to the broader market. As of the most recent ...